Caspofungin in salvage treatment of severe pneumocystis pneumonia： case report and literature review  

作　　者：MU Xiang-dong QUE Cheng-li HE Bing WANG Guang-fa LI Hai-chao 

机构地区：[1]Department of Respiratory Medicine, Peking University First Hospital, Beijing 100034, China

出　　处：《Chinese Medical Journal》2009年第8期996-999,共4页中华医学杂志（英文版）

摘　　要：Pneumocystis pneumonia （PCP） is one of the most critical and life-threatening infections in immunocompromised patients with AIDS （especially CD4^＋ T cell less than 0.2×10^9/L）, hematological malignancies, organ transplantation or connective tissue diseases. It is caused by a fungus called Pneumocystis jiroveci （P. jiroveci, formerly called P carinii）.Pneumocystis pneumonia （PCP） is one of the most critical and life-threatening infections in immunocompromised patients with AIDS （especially CD4^＋ T cell less than 0.2×10^9/L）, hematological malignancies, organ transplantation or connective tissue diseases. It is caused by a fungus called Pneumocystis jiroveci （P. jiroveci, formerly called P carinii）.

关 键 词：pneumocystis jiroveci pneumonia 1  3-beta-D-glucan CASPOFUNGIN TRIMETHOPRIM-SULFAMETHOXAZOLE 

分 类 号：R512.91[医药卫生—内科学] R696.1[医药卫生—临床医学]